ArticleDiseases (Basel, Switzerland)2025
Clinical Implications of Upregulated
Leung Li, Nelson L S Tang, Stephen L Chan, David Ryan Johnson, Frankie Mo, Jane Koh, Tsz-Ki Kwan, Edwin P Hui, Landon Long Chan, Kit F Lee and 2 more
Abstract read
In one paragraphArticle in Diseases (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Leung LiState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-0251-0253 Nelson L S TangDepartment of Chemical Pathology, Prince of Wales Hospital, Faculty of Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-3607-5819 Stephen L ChanState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-8998-5480 David Ryan JohnsonState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0009-0001-1479-1224 Frankie MoState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-0566-3212 Jane KohState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-1034-2042 Edwin P HuiState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-8134-7019 Landon Long ChanState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-1306-5896 Kit F LeeDepartment of Surgery, Prince of Wales Hospital, Shatin, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Simon Chun Ho YuDepartment of Diagnostic and Interventional Radiology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-8715-5026 Winnie YeoState Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-0863-8469 Funding
Co-funding Mechanism on Joint Laboratories with the CAS - KIZ-CUHK Joint Laboratory of Bio-resources and Molecular Research in Common Diseases JLFS/M-403/24
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
liver cancermessenger ribonucleic acidquality of lifequantitative real-time polymerase chain reactionviperin
Identifiers
PMID41439936
PMCPMC12731563
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390